Rx/Reimbursement Adult Incontinence in Switzerland

Value sales of Rx/reimbursement adult incontinence products rose in 2024. The increase was driven by a growing elderly population requiring long-term care and more consistent support in managing incontinence. In the context of economic uncertainty, many consumers turned to the healthcare system to obtain prescriptions for reimbursable products, reducing their personal financial burden. This has contributed to a rise in consultations and an increased uptake of reimbursed products, particularly am...

Euromonitor International's Rx/Reimbursement adult incontinence in Switzerland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2020-2024, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, distribution or pricing issues. Forecasts to 2029 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Rx/Reimbursement adult incontinence market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.